Levetiracetam for Seizure Emergencies in Children
Part of Brain & nervous system clinical trials.
This study looks back at children who had a prolonged seizure (status epilepticus) and needed a second medicine after the first one didn't work. Doctors want to see how well levetiracetam works compared to phenytoin, so they can choose better treatments for future children.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 3 months and 17 years old.
- Your child had a seizure that didn't stop after the first rescue medicine, and they were given either levetiracetam or phenytoin as a second medicine.
- Your child was treated at one of the study hospitals between November 1, 2019, and May 31, 2023.
- You (and your child, if old enough) have not objected to your child's medical information being used for research.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two antiseizure medicines, levetiracetam and phenobarbital, to see which one works better for children whose prolonged seizures (lasting several minutes) do not stop after two doses of a rescue medicine called benzodiazepine.
This study tests whether two medicines, ketamine (a sleep medicine) and levetiracetam (a seizure medicine), work better than a standard treatment for stopping long-lasting seizures in children when the first rescue medicine doesn't work.
This trial studies how to give levetiracetam to newborn babies with seizures. It’s trying to find a safe dose and see if it can help control seizures in early life.
This trial is for adults with uncontrolled epilepsy who have been taking a high dose of Levetiracetam alone for at least a year. It tests whether taking Levetiracetam three times a day works better than the usual schedule.
This trial tests if adding ketamine to standard care can stop seizures that continue after a first treatment. It is for people having a convulsive seizure lasting more than 5 minutes and who are still seizing in the emergency room.
This study compares stopping seizure medicine (levetiracetam) after 6 months versus continuing it longer for people with primary brain tumors. It aims to find out if it is safe to stop the medication sooner and may help you avoid long-term side effects.
Hear when a new Epilepsy in Children trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.